Syndax (SNDX) news
Recent news
Plans for KNDs IPO put on hold for now, source familiar with matter says
Defense company KNDS has temporarily paused its plans for an initial public offering (IPO), according to a source familiar with the matter . The company had previously announced its intention to list shares in Paris and Frankfurt as part of a strategy to support long-term growth . The IPO was…
AInvest Wire · 11h agoRenk, KNDs sign Leopard 2 contract extension worth around EUR 130M
AInvest Wire · 18h agoSyndax Pharmaceuticals, Inc.: BofA global research cuts price objective to $23 from $26
AInvest Wire · 1d agoIncyte sharefollow Syndax lower postmarket, down 3.9%
Incyte Corp. (INCY) shares declined postmarket on October 12, 2026, falling 3.9% following news related to Syndax Pharmaceuticals. The drop came amid market reactions to updated clinical or partnership developments involving Syndax, which has a collaboration with Incyte in the oncology space. While…
AInvest Wire · 2d agoSyndax Pharmaceuticals - Axatlimab continues in multiple CGVHD trials with results expected later this year and early 2028
AInvest Wire · 2d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.